Hinton J P, Jennings K, Johnson E L, Wright D S
Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, MI 48105, USA.
Biomed Chromatogr. 1995 Mar-Apr;9(2):94-7. doi: 10.1002/bmc.1130090208.
A sensitive and specific high-performance liquid chromatographic assay for the non-peptide cholecystokinin subtype B receptor antagonist, CI-988, in human and cynomolgus monkey plasma has been developed and validated. The method involves isolation of CI-988 and internal standard by batch robotic solid phase extraction with a C18 cartridge, liquid chromatographic separation on a C18 column and quantitation by fluorescence detection. The human plasma assay is linear from 0.25 to 500 ng/mL for a 1.00-mL plasma aliquot. Assay precision for CI-988 based on human plasma quality control samples was within +/- 7.2% relative standard deviation with an accuracy of +/- 5.6% relative error. The monkey plasma assay is linear from 1.00 to 250 ng/mL for a 0.500-mL plasma aliquot. Assay precision based on monkey plasma quality control samples was within +/- 11.0% relative standard deviation with an accuracy of +/- 2.6% relative error.
已开发并验证了一种灵敏且特异的高效液相色谱法,用于测定人和食蟹猴血浆中的非肽类胆囊收缩素B型受体拮抗剂CI-988。该方法包括用C18柱通过批量机器人固相萃取分离CI-988和内标,在C18柱上进行液相色谱分离,并通过荧光检测进行定量。对于1.00 mL血浆等分试样,人血浆测定法在0.25至500 ng/mL范围内呈线性。基于人血浆质量控制样品的CI-988测定精密度在相对标准偏差±7.2%以内,相对误差准确度在±5.6%以内。对于0.500 mL血浆等分试样,猴血浆测定法在1.00至250 ng/mL范围内呈线性。基于猴血浆质量控制样品的测定精密度在相对标准偏差±11.0%以内,相对误差准确度在±2.6%以内。